Choi Sung-wonChoi Sung-won, president and CEO of Kwang Dong Pharmaceutical Co., was promoted to vice chairman. Choi, 45, has served as CEO of Kwang Dong since July 2013 when his father Choi Soo-boo, founder and chairman of the drug manufacturer, died at the age of 77. He plans to transform the company into Korea's leading healthcare provider, with the goal of generating 1 trillion won ($910 million) in sales by 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,820 KRW | +1.04% | +4.44% | -8.21% |
1st Jan change | Capi. | |
---|---|---|
-8.21% | 198M | |
+20.76% | 43.54B | |
+18.62% | 21.51B | |
+18.70% | 15.34B | |
+26.36% | 15.12B | |
+56.55% | 13.37B | |
-0.05% | 6.79B | |
-14.94% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.36B |
- Stock Market
- Equities
- A009290 Stock
- News Kwang Dong Pharmaceutical Co., Ltd.
- Kwang Dong Pharmaceutical Announces Promotion of Choi Sung-Wonchoi Sung-Won to Vice Chairman